NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.

Vaccines, Free Full-Text

SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people - ScienceDirect

Recent Advancement of Nanostructured Materials for Clinical Challenges in Vaccinology

The National Institutes of Health on LinkedIn: Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time

Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action - ScienceDirect

How the Coronavirus Affects People With Mesothelioma

Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory - ScienceDirect

Research Spotlight - Kaiser Permanente Division of Research

NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

PDF) Spontaneous tumor regression following COVID-19 vaccination